Facilities
- All
- APIs
- Aseptic Processing
- cGMP Manufacture
- Cleaning Validation
- Clinical Trial Materials
- Cytotoxics and High Potency Manufacturing
- Excipients
- Extractables and Leachables
- Facilities
- Fill/Finish
- Lyophilization
- Parenterals
- Process Development
- Process Validation
- Risk Management
- Scale-up/ Technology Transfer
- Solid Dosage/ Creams/ Ointments
-
Clinical Trial Materials | Cytotoxics and High Potency Manufacturing | Facilities | Process Development | Scale-up/ Technology Transfer
ADC Bio Invests $11M in Bioconjugation Facility
Will provide capabilities and R&D technical services from process development through to manufacturing09.25.17
-
Breaking News | Cold Chain Management | Facilities | Industry News | Packaging & Tracking
PCI Expands Cold Chain Capacity
Investment in Philadelphia site is a considerable expansion of onsite cold chain storage09.20.17
-
Breaking News | Facilities | Industry News | Solid Dosage/ Creams/ Ointments
Recipharm, Roche Sign Long-term Mfg. Deal
CDMO to manufacture solid dose products and acquires facility in Spain09.20.17
-
Breaking News | Clinical Trial Materials | Cold Chain Management | Facilities | Industry News
Catalent Expands Clinical Storage Capacity
Invests $5.5 million in Philadelphia site to increase clinical storage capacity09.18.17
-
Bio News | Breaking News | Facilities | Industry News
Fujifilm Diosynth Biotechnologies Expands UK Operations
Opens cell culture process development laboratories in Wilton Centre09.12.17
-
Bio News | Breaking News | Facilities | Industry News
Kaneka Eurogentec to Build Biologics Mfg. Facility
Will allow GMP production of kg scale plasmid DNA and recombinant protein intended for clinical phases and commercialization09.12.17
-
Bio News | Breaking News | Facilities | Industry News
Oxford Genetics Supports Growth with New U.S. Office
Company to extend its presence into the U.S. as a key cell and gene therapy market09.12.17
-
Breaking News | Facilities | Industry News | Solid Dosage/ Creams/ Ointments
-
APIs | Breaking News | Facilities | Industry News
Alcami to Establish API Center of Excellence
Demand for end-to-end services spurs decision to expand09.07.17
-
Breaking News | CRO News | Facilities | Industry News
Clintec Expands UK HQ
CRO also presented with Queens Award for Enterprise – International Trade09.06.17
-
Breaking News | Facilities | Industry News
Colorcon Opens New Technology Services Laboratory in Vietnam
Marks the sixth such facility for Colorcon within Southeast Asia09.05.17
-
Breaking News | cGMP Manufacture | Collaborations & Alliances | Facilities | Industry News
Catalent Signs Commercial Mfg. Agreement with US WorldMeds
Will manufacture lofexidine, an investigational drug under development to mitigate symptoms associated with opioid withdrawal09.05.17
-
Breaking News | cGMP Manufacture | Facilities | Industry News | Injectables | Parenterals | Vials
Navesta Opens Sterile Mfg. Plant
Sri Lanka’s first EU-GMP, PIC/S compliant facility to enable exports of pharmaceuticals to international markets09.01.17
-
APIs | Breaking News | Facilities | Industry News
-
APIs | Breaking News | Facilities | Industry News
Cambrex Expands NC Facility
Invests $3.2mn in new analytical development and method validation lab08.30.17
-
Breaking News | Capsules | cGMP Manufacture | Facilities | Industry News | Solid Dosage/ Creams/ Ointments
CDMO to Invest €19m in GMP Facility Expansion
Micro-Sphere responds to increased market demand for spray drying and capsule filling for dry powder inhalers08.22.17
-
Breaking News | Facilities | Industry News
CordenPharma Expands Capabilities
Invests €10 million in new manufacturing line for veterinary drug products08.16.17
-
Breaking News | Facilities | Industry News | Inspections
Aerie Pharma’s CMO Receives FDA CRL
Was issued in response to CGMP inspection at Tampa facility08.10.17
-
APIs | Aseptic Processing | Breaking News | Facilities | Industry News
Avara Acquires Sterile Facility from Pfizer in Italy
Expands the CDMO’s services by adding sterile processing capability08.09.17
-
APIs | Breaking News | Cytotoxics and High Potency Manufacturing | Facilities | Industry News
Cambrex Expands HPAPI Footprint
Invests $24 million in new highly potent API manufacturing capacity at its Charles City, IA facility08.09.17
